Table 3.
Variable | Preoperative SR (n = 333) |
---|---|
Heart rhythm 12 months after surgery | |
Sinus rhythm | 70.3 |
Atrial fibrillation | 29.7 |
Paroxysmal | 16.1 |
Persistent | 9.8 |
Long-term persistent | 3.8 |
AF recurrence after three months and/or current AF | 34.4 |
No AF during follow-up * | 67.2 |
AF recurrence | |
During the blanking period (≤3 months) | 23.6 |
Symptomatic | 15.1 |
Asymptomatic | 11.2 |
After the blanking period (>3 months) | 25.7 |
Symptomatic | 16.4 |
Asymptomatic | 13.3 |
Arrhythmia diagnostics | |
Resting ECG | 80.3 |
Long-term ECG (24 h) | 74.2 |
Cardiac electrical device testing | 3.7 |
mEHRA classification | |
I (No) | 70.5 |
IIa (Mild) | 26.7 |
IIb (Moderate) | 1.2 |
III (Severe) | 0.8 |
IV (Disabling) | 0.8 |
AF episode frequency | |
Occasionally | 52.9 |
Moderately frequent | 9.8 |
Frequent | 5.2 |
Undecided | 32.0 |
Medication | |
Antiarrhythmic drugs | |
Class I | 2.7 |
Class II | 83.1 |
Class III | 8.0 |
Digitalis | 2.7 |
Anticoagulation | 56.8 |
DOAC | 65.3 |
VKA | 33.5 |
Antiplatelet therapy | 36.2 |
Categorical variables are presented as percentages. Abbreviations: AF, atrial fibrillation; DOAC, direct oral anticoagulants; ECG, electrocardiogram; mEHRA, modified European Heart Rhythm Association symptom classification; SR, sinus rhythm; VKA, vitamin K antagonist; *, combined endpoint of no AF recurrences at three months + no current AF + no re-ablation + no cardioversion + no rehospitalization for AF.